Z Growth Portfolio Update: July 2020

EXECUTIVE SUMMARY:

Z Growth beat the market for the second month in a row; including GMED’s lackluster performance. It’s important to note however that as of today, GMED is up considerably.

Please see the breakdowns below for more information.

Cumulative Portfolio Unrealized G/L %: +10.73%

Market Index G/L %: +5.98%

Z Growth Performance Ratio for July 2020: 1.79 to 1

PORTFOLIO COMPOSITION:

Nvidia (NVDA)

• Bought on 6.2.2020 @ 348.34
• Value on 7.31.2020 @ 424.59
• Unrealized G/L: +21.89%

ServiceNow (NOW)

• Bought on 6.3.2020 @ 385.20
• Value on 7.31.2020 @ 439.20
• Unrealized G/L: +15.07%

Crowdstrike (CRWD)

• Bought on 6.4.2020 @ 96.41
• Value on 7.31.2020 @ 113.20
• Unrealized G/L: +17.41%

Globus Medical (GMED)

• Bought on 6.4.2020 @ 54.42
• Value on 7.31.2020 @ 48.18
• Unrealized: -11.44%

COMPARISON BENCHMARK:

S&P 500 ETF (SPY)

• Bought on 6.2.2020 @ 308.08
• Value on 7.31.2020 @ 326.52
• Unrealized G/L: +5.98%

DISCLOSURES:

Zilos does not sit on the Board of Directors for any of these companies. We may adjust our position sizes at any time (even to 0). These were stocks we actually held real shares of at the time of publishing the original post. We receive(d) no compensation for writing about these companies. We hold more stocks in our portfolio than just these which could impact our total profit loss figures in either direction. None of our content (this post included) should ever be construed apart from it’s original intent, to demonstrate the opportunity the equities markets provides – and should not be used as or in lieu of financial advice. Stocks can gain and/or lose value regularly.